Article
Linking genetic susceptibility and T cell activation in beryllium-induced disease.
Proceedings of the American Thoracic Society - 1 May 2010
Falta Michael T, Bowerman Natalie A, Dai Shaodong, Kappler John W, Fontenot Andrew P
Abstract excerpt
Chronic beryllium disease (CBD) is a granulomatous lung disorder caused by beryllium (Be) exposure in the workplace. It is characterized by the accumulation of Be-specific CD4(+) T cells in the lung as well as persistent lung inflammation, culminating in the development of lung fibrosis. CBD occurs in 2 to 16% of Be-exposed workers depending on the individuals' genetic susceptibility and the characteristics of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
